| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |